spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Trilogy Writing & Consulting Gains PIF TICK Accreditation To Be Recognised As A ‘Trusted Information Creator’

Trilogy Writing & Consulting




Trilogy Writing & Consulting has been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information.

To be awarded the ‘trusted information creator’ status, Trilogy had to undergo an assessment showing it met 10 key criteria. This means you can be assured that what you are reading, watching, or listening to is evidence-based, understandable, jargon-free, up-to-date, and produced to the best possible standard.

Lisa Chamberlain James, Senior Partner at Trilogy Writing & Consulting, said: “Gaining the PIF TICK shows we have a strong process for developing our clinical and scientific communication documents. It is clear that the demand and need for information for the non-specialist audience is growing, and it is equally clear that with the current information overload it is difficult to know what to trust. This quality mark is an unequivocal way for people to be assured our information is reliable and trustworthy.

The PIF TICK, which launched in May 2020, is run by the non-profit Patient Information Forum (PIF).

In July 2021, a public website, www.piftick.org.uk, was launched to raise awareness of PIF TICK-accredited members and help people find trusted health information. The site also includes guides on topics including spotting false health information and understanding evidence.

PIF TICK manager Dan Wills said: “We are thrilled to welcome Trilogy Writing & Consulting to our ever-growing community of accredited PIF TICK members. Accurate, accessible, evidence-based information is key to increasing patient empowerment and improving health outcomes.

Contact Information:
Trilogy Writing & Consulting
Phone: 49 69 138 2528-0 (HQ)

PIF TICK
phone +49 69 138 2528 0
web www.trilogywriting.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Winterlight Labs announces data demonstrating the sensitivity of speech-based digital measures in detecting longitudinal change in Alzheimer’s disease in collaboration with Genentech


More info >>


White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement